	US 11,931,369 B1
	Compositions and methods for treating epilepsy
John Docherty, Port Perry (CA); and Christopher Andrew Bunka, Kelowna (CA)
Assigned to POVIVA CORP, Carson City, NV (US)
Filed by POVIVA CORP, Carson City, NV (US)
Filed on Jul. 24, 2023, as Appl. No. 18/225,227.
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/00 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/28 (2006.01); A61P 25/08 (2006.01)

CPC A61K 31/658 (2023.05) [A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/28 (2013.01); A61P 25/08 (2018.01)]

12 Claims

1. A composition, consisting of:

a) about 35 mg of cannabidiol oil (CBD oil) extract containing at least about 98% by weight of cannabidiol;

b) about 70 mg of olive oil;

c) about 3 mg of deoxycholic acid;

d) about 67 mg of mannitol and about 68 mg of colloidal silicon dioxide.